Cannashield Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
Mainstream Brands Join the Cannabis Space with Hemp-Derived THC Products (Copy)
Congress’s latest budget deal would restrict hemp-derived THC products while removing provisions allowing VA doctors to recommend medical marijuana. The move tightens federal hemp oversight and highlights how cannabis reform momentum is slowing at the national level.
Hemp and the Hill: How a Federal Funding Bill Sparked a Cannabis Policy Standoff
Lawmakers are clashing over hemp-derived THC restrictions as part of a federal funding bill, sparking a political standoff that could shape the future of hemp regulation. The outcome could redefine how hemp and cannabis are governed nationwide.
Missouri Cracks Down on Hemp-Derived THC Beverages as Market Booms
Missouri regulators are preparing enforcement actions against the state’s booming hemp-derived THC beverage market, which is projected to grow 25% in 2025. As federal oversight remains unclear, Missouri joins other states in tightening control to protect consumers and ensure market integrity.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to get you cover?
Call us on (323)905-3396
or growth@cannashield.io
France is moving toward medical cannabis reimbursement, and that shift changes everything from product standards to investment expectations. Here is the operator playbook for a pharma style market.